Drexel Morgan & Co. Gilead Sciences, Inc. Transaction History

Drexel Morgan & Co.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $465,097 - $501,789	-6,871 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $110,120 - $120,322	-1,735 Reduced 20.16%	6,871 $473,000
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $20,583 - $26,860	-340 Reduced 3.8%	8,606 $538,000
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $580,416 - $677,033	8,946 New	8,946 $634,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Drexel Morgan & Co., based on Form 13F filings with the SEC.

Stay updated on Drexel Morgan & Co. with notifications on news.